Skip to main content
. 2023 Mar 14;44(19):1748–1760. doi: 10.1093/eurheartj/ehad114

Structured Graphical Abstract.

Structured Graphical Abstract

Mesenchymal stem cell–derived extracellular vesicles and LNP–TARID treatment improved myocardial fibrosis by up-regulating Tcf21 via supplementing lncRNA–TARID. Tcf21 antagonizes TGF-β/Smad3 signalling pathway to suppress myofibroblast differentiation from epicardial cells. The cardiac histology and function were improved after such therapeutics. EVs, extracellular vesicles; lncRNA, long non-coding RNA; LNP–TARID, lncRNA–TARID laden lipid nanoparticles.